CRO & BIOTECH

Ascentia is a Contract Research Organization (CRO) composed of virtuosos in medicinal chemistry and molecular biology. Our operations are built around the design, synthesis, and evaluation of small molecules, addressing a wide range of our clients’ needs.

As a CRO partner, we collaborate with biotechnology companies, pharmaceutical corporations, and academic research groups-providing access to our integrated expertise in medicinal chemistry, organic synthesis, molecular biology, and computer-aided drug design. Whether supporting early-stage drug discovery, optimizing lead compounds, or scaling up complex syntheses, Ascentia delivers flexible, science-driven solutions tailored to our clients’ R&D objectives.

In addition to providing CRO services, we also conduct our own research and development projects, and we are creating a library of unique building blocks with a high content of C-sp3 carbons.